New Delhi, June 22 (KNN) The government will support micro, small and medium enterprises (MSMEs) in Pharmaceutical Industry of proven track record to meet national and international regulatory standards under the Pharmaceutical Technology Upgradation Assistance Scheme (PTUAS).

Interest subvention or capital subsidy on their capital loans will be provided, which will further facilitate the growth in volumes as well as in quality.

The Ministry of Chemicals and Fertilizers had recently released the guidelines for the scheme “Strengthening of Pharmaceutical Industry (SPI)", with a total financial outlay of Rs 500 crore for the period from FY 21-22 to FY 25-26.

Under the scheme, financial assistance to pharma clusters will be provided for creation of Common Facilities.

PTUAS is a sub scheme of the SPI scheme. The two other sub schemes are Assistance to Pharmaceutical Industry for Common Facilities (APICF) and Pharmaceutical & Medical Devices Promotion and Development Scheme (PMPDS).

APICF focuses on strengthening the existing pharmaceutical clusters’ capacity for their sustained growth by creating common facilities.

Under this, support for clusters for creation of common facilities with the focus on R&D (Research and Development) Labs, Testing Laboratories, Effluent Treatment Plants, Logistic Centers and Training Centres in this order of priority with an outlay of Rs 178 crore is proposed.

The aim of PMPDS is to facilitate growth and development of Pharmaceutical and Medical Devices Sectors through study/survey reports, awareness programs, creation of database, and promotion of industry.  (KNN Bureau)